Cargando…

Amiodarone exacerbates brain injuries after hypoxic–ischemic insult in mice

BACKGROUND: Sodium ion transportation plays a crucial role in the pathogenesis of hypoxic–ischemic brain injury. Amiodarone, a Vaughan-Williams class III antiarrhythmic drug, has been widely used to treat life-threatening arrhythmia and cardiac arrest worldwide. In addition to its inhibitory effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotoda, Masakazu, Hishiyama, Sohei, Ishiyama, Tadahiko, Mitsui, Kazuha, Matsukawa, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925851/
https://www.ncbi.nlm.nih.gov/pubmed/31864286
http://dx.doi.org/10.1186/s12868-019-0544-2
_version_ 1783481990200164352
author Kotoda, Masakazu
Hishiyama, Sohei
Ishiyama, Tadahiko
Mitsui, Kazuha
Matsukawa, Takashi
author_facet Kotoda, Masakazu
Hishiyama, Sohei
Ishiyama, Tadahiko
Mitsui, Kazuha
Matsukawa, Takashi
author_sort Kotoda, Masakazu
collection PubMed
description BACKGROUND: Sodium ion transportation plays a crucial role in the pathogenesis of hypoxic–ischemic brain injury. Amiodarone, a Vaughan-Williams class III antiarrhythmic drug, has been widely used to treat life-threatening arrhythmia and cardiac arrest worldwide. In addition to its inhibitory effects on the potassium channel, amiodarone also blocks various sodium ion transporters, including the voltage-gated sodium channel, sodium pump, and Na(+)/Ca(+) exchanger. Considering these pharmacological profile, amiodarone may affect the influx–efflux balance of sodium ion in the hypoxic–ischemic brain. Previous studies suggest that the blockade of the voltage-gated sodium channel during hypoxic–ischemic brain injury exerts neuroprotection. On the contrary, the blockade of sodium pump or Na(+)/Ca(+) exchanger during hypoxia–ischemia may cause further intracellular sodium accumulation and consequent osmotic cell death. From these perspectives, the effects of amiodarone on sodium ion balance on the hypoxic–ischemic brain can be both protective and detrimental depending on the clinical and pathophysiological conditions. In this study, we therefore investigated the effect of amiodarone on hypoxic–ischemic brain injury using a murine experimental model. RESULTS: Compared with the control group mice, mice that received amiodarone after induction of 40-min hypoxic–ischemic brain injury exhibited lower survival rates over 7 days and worse neurological function. After 25-min hypoxic–ischemic brain injury, amiodarone treated mice exhibited larger infarct volumes (16.0 ± 6.9 vs. 24.2 ± 6.8 mm(3), P < 0.05) and worse neurological function. In addition, the brains harvested from the amiodarone-treated mice contained larger amounts of sodium (194.7 ± 45.1 vs. 253.5 ± 50.9 mEq/kg dry weight, P < 0.01) and water (259.3 ± 8.9 vs. 277.2 ± 12.5 mg, P < 0.01). There were no significant differences in hemodynamic parameters between groups. CONCLUSIONS: Amiodarone exacerbated brain injuries and neurological outcomes after hypoxic–ischemic insults. Severe brain sodium accumulation and brain edema were associated with the detrimental effects of amiodarone. Amiodarone at the clinical dose can exacerbate brain injury after hypoxic–ischemic insult by affecting sodium ion transportation and facilitate intracellular sodium accumulation in the brain.
format Online
Article
Text
id pubmed-6925851
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69258512019-12-30 Amiodarone exacerbates brain injuries after hypoxic–ischemic insult in mice Kotoda, Masakazu Hishiyama, Sohei Ishiyama, Tadahiko Mitsui, Kazuha Matsukawa, Takashi BMC Neurosci Research Article BACKGROUND: Sodium ion transportation plays a crucial role in the pathogenesis of hypoxic–ischemic brain injury. Amiodarone, a Vaughan-Williams class III antiarrhythmic drug, has been widely used to treat life-threatening arrhythmia and cardiac arrest worldwide. In addition to its inhibitory effects on the potassium channel, amiodarone also blocks various sodium ion transporters, including the voltage-gated sodium channel, sodium pump, and Na(+)/Ca(+) exchanger. Considering these pharmacological profile, amiodarone may affect the influx–efflux balance of sodium ion in the hypoxic–ischemic brain. Previous studies suggest that the blockade of the voltage-gated sodium channel during hypoxic–ischemic brain injury exerts neuroprotection. On the contrary, the blockade of sodium pump or Na(+)/Ca(+) exchanger during hypoxia–ischemia may cause further intracellular sodium accumulation and consequent osmotic cell death. From these perspectives, the effects of amiodarone on sodium ion balance on the hypoxic–ischemic brain can be both protective and detrimental depending on the clinical and pathophysiological conditions. In this study, we therefore investigated the effect of amiodarone on hypoxic–ischemic brain injury using a murine experimental model. RESULTS: Compared with the control group mice, mice that received amiodarone after induction of 40-min hypoxic–ischemic brain injury exhibited lower survival rates over 7 days and worse neurological function. After 25-min hypoxic–ischemic brain injury, amiodarone treated mice exhibited larger infarct volumes (16.0 ± 6.9 vs. 24.2 ± 6.8 mm(3), P < 0.05) and worse neurological function. In addition, the brains harvested from the amiodarone-treated mice contained larger amounts of sodium (194.7 ± 45.1 vs. 253.5 ± 50.9 mEq/kg dry weight, P < 0.01) and water (259.3 ± 8.9 vs. 277.2 ± 12.5 mg, P < 0.01). There were no significant differences in hemodynamic parameters between groups. CONCLUSIONS: Amiodarone exacerbated brain injuries and neurological outcomes after hypoxic–ischemic insults. Severe brain sodium accumulation and brain edema were associated with the detrimental effects of amiodarone. Amiodarone at the clinical dose can exacerbate brain injury after hypoxic–ischemic insult by affecting sodium ion transportation and facilitate intracellular sodium accumulation in the brain. BioMed Central 2019-12-21 /pmc/articles/PMC6925851/ /pubmed/31864286 http://dx.doi.org/10.1186/s12868-019-0544-2 Text en © The Author(s) 2019 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Kotoda, Masakazu
Hishiyama, Sohei
Ishiyama, Tadahiko
Mitsui, Kazuha
Matsukawa, Takashi
Amiodarone exacerbates brain injuries after hypoxic–ischemic insult in mice
title Amiodarone exacerbates brain injuries after hypoxic–ischemic insult in mice
title_full Amiodarone exacerbates brain injuries after hypoxic–ischemic insult in mice
title_fullStr Amiodarone exacerbates brain injuries after hypoxic–ischemic insult in mice
title_full_unstemmed Amiodarone exacerbates brain injuries after hypoxic–ischemic insult in mice
title_short Amiodarone exacerbates brain injuries after hypoxic–ischemic insult in mice
title_sort amiodarone exacerbates brain injuries after hypoxic–ischemic insult in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925851/
https://www.ncbi.nlm.nih.gov/pubmed/31864286
http://dx.doi.org/10.1186/s12868-019-0544-2
work_keys_str_mv AT kotodamasakazu amiodaroneexacerbatesbraininjuriesafterhypoxicischemicinsultinmice
AT hishiyamasohei amiodaroneexacerbatesbraininjuriesafterhypoxicischemicinsultinmice
AT ishiyamatadahiko amiodaroneexacerbatesbraininjuriesafterhypoxicischemicinsultinmice
AT mitsuikazuha amiodaroneexacerbatesbraininjuriesafterhypoxicischemicinsultinmice
AT matsukawatakashi amiodaroneexacerbatesbraininjuriesafterhypoxicischemicinsultinmice